More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

The disease is an accumulation of excess fat in the liver and commonly affects those that could afford to lose a few pounds, ...

New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals that 3 to ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

Anti-obesity drug popularity presents opportunities for science innovation. Strategies to increase protein and fiber can help prevent side effects.

Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...

Patients with atopic dermatitis had an increased risk for COVID-19 infection despite age and sex, and some comorbidities were linked to a greater risk.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...